Osteosarcoma late dying symptoms?

summary

Osteosarcoma is a very common tumor disease in our daily life, and for this disease, the incidence of the population is also very concentrated, the most important is for some teenagers. Moreover, this disease is very harmful to teenagers. If the patients do not pay attention to their personal conditioning and treatment in time when they have this disease, then other diseases will appear indirectly. Osteosarcoma late dying symptoms now tell you.

Osteosarcoma late dying symptoms?

Osteosarcoma is also one of the malignant tumors in the bone. As we all know, any malignant disease will do great harm to our body. Moreover, when this disease occurs, patients may have paralysis of some joints due to lack of timely treatment. In this case, it may affect the academic problems of teenagers. So whether it is for patients or their families, we must pay attention to this disease.

And when osteosarcoma develops to the late stage, the symptoms will be more obvious. First of all, the patient's body will have persistent fever, and the weight will continue to decrease, which is particularly prone to fatigue in daily life. And some joints will appear paralysis, renal failure, anemia and other symptoms will gradually appear, and in walking or doing other things, joints may appear different degrees of pain, if it is like this, then some patients can only lie on the bed can't carry out any activities, don't regret after the body can't move.

As for osteosarcoma, there are many variables in the symptoms. For example, in daily life, some symptoms will appear in the short term because of bad living habits or eating habits. When the disease develops to the late stage, the symptoms will be different. Like fever, weight loss and so on.

matters needing attention

Because the malignant degree of osteosarcoma is very high, so the current surgical method is amputation. During the operation, we should pay attention to the operation without tumor and try to avoid the implantation or distant metastasis caused by the operation. For the isolated lesions with local recurrence or distant metastasis, it is suggested that preoperative chemotherapy plus surgical resection plus postoperative chemotherapy should still be used, which may still have a better prognosis. Chemotherapy, supportive treatment and radiotherapy of key sites can be used for distant metastasis. The purpose is to support and reduce the pain of patients as much as possible. The prognosis of such patients is very poor.